[
    [
        {
            "time": "",
            "original_text": "贵司引进俄罗斯新冠疫苗需要再在国内做3期临床试验吗？华兰生物：正在进行相关疫苗的技术转移工作",
            "features": {
                "keywords": [
                    "华兰生物",
                    "俄罗斯",
                    "新冠疫苗",
                    "技术转移",
                    "临床试验"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贵司引进俄罗斯新冠疫苗需要再在国内做3期临床试验吗？华兰生物：正在进行相关疫苗的技术转移工作",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华兰生物：2021年1-5月份未新增单采血浆站",
            "features": {
                "keywords": [
                    "华兰生物",
                    "单采血浆站",
                    "2021年"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物：2021年1-5月份未新增单采血浆站",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华兰生物：目前疫苗公司分拆上市尚在稳步推进",
            "features": {
                "keywords": [
                    "华兰生物",
                    "疫苗公司",
                    "分拆上市",
                    "稳步推进"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华兰生物：目前疫苗公司分拆上市尚在稳步推进",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华兰生物：分拆疫苗公司上市和研发新冠疫苗我们都在加快推进，不会出现刻意拖延的情况",
            "features": {
                "keywords": [
                    "华兰生物",
                    "分拆上市",
                    "新冠疫苗",
                    "加快推进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华兰生物：分拆疫苗公司上市和研发新冠疫苗我们都在加快推进，不会出现刻意拖延的情况",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华兰生物：目前正申请分拆疫苗公司在深交所创业板上市，目前处于二轮问询回复过程中",
            "features": {
                "keywords": [
                    "华兰生物",
                    "分拆上市",
                    "深交所",
                    "创业板",
                    "二轮问询"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华兰生物：目前正申请分拆疫苗公司在深交所创业板上市，目前处于二轮问询回复过程中",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]